Nifty

:

24565.35

Sensex

:

80599.91

-203.00 (-0.82%)
-585.67 (-0.72%)

Login

Nifty
Sensex

:
:

24565.35
80599.91

-203.00 (-0.82%)
-585.67 (-0.72%)

Yatharth Hospital & Trauma Care Services Ltd.

Hospital & Healthcare Services

Rating :

76/99

BSE: 543950 | NSE: YATHARTH

Watchlist

NSE BSE

636.55

01-Aug-2025

Open
High
Low
Previous Close

649.25
650
634
643.95

Volume
Traded Value (lacs)
52 Week High
52 Week Low

246689
158535597.5
693
345.6

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

6,125.73
46.92
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

5,689.25
N/A
3.82

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-
-
18.70

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
-
10.20

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-
37.37

P:E (Median)

8 Years
5 Years
3 Years

-
-
-

P:BV (Average)

8 Years
5 Years
3 Years

-
-
-

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-
-
-

Earnings Forecasts:

(Updated: 06-06-2025)

Description 2024 2025 2026 2027
Adj EPS 14.46 14.72 19.09 26.02
P/E Ratio 44.02 43.24 33.34 24.46
Revenue 671 880 1163 1590
EBITDA 180 292 402
Net Income 114 131 178 245
ROA 15.2 4.8 5.4
P/B Ratio 6.53 3.33 2.92
ROE 21.65 11.78 13.52
FCFF -93 2 42
FCFF Yield -1.93 0.04 0.88
Net Debt -154 -315 -424
BVPS 97.49 191.1 217.88

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var%
Net Sales 111.99 105.59 6.06% 110.41 101.73 8.53% 112.87 110.12 2.50% 118.96 102.34 16.24%
Expenses 80.22 78.00 2.85% 78.61 72.40 8.58% 82.21 78.83 4.29% 86.18 73.25 17.65%
EBITDA 31.78 27.59 15.19% 31.80 29.33 8.42% 30.66 31.29 -2.01% 32.78 29.09 12.68%
EBIDTM 28.37% 26.13% 28.80% 28.83% 27.16% 28.42% 27.56% 28.43%
Other Income 4.10 5.06 -18.97% 3.15 4.75 -33.68% 1.81 3.35 -45.97% 2.63 0.40 557.50%
Interest 0.15 0.19 -21.05% 0.15 0.13 15.38% 0.21 1.57 -86.62% 0.11 2.42 -95.45%
Depreciation 4.71 3.15 49.52% 5.19 3.97 30.73% 4.77 3.17 50.47% 4.00 3.16 26.58%
PBT 31.01 29.32 5.76% 29.62 29.98 -1.20% 27.49 29.91 -8.09% 31.31 23.91 30.95%
Tax 9.12 3.08 196.10% 7.37 8.88 -17.00% 7.09 8.86 -19.98% 8.16 8.30 -1.69%
PAT 21.89 26.24 -16.58% 22.25 21.10 5.45% 20.40 21.04 -3.04% 23.15 15.61 48.30%
PATM 19.55% 24.85% 20.16% 20.74% 18.07% 19.11% 19.46% 15.25%
EPS 2.27 2.72 -16.54% 2.31 2.19 5.48% 2.12 2.18 -2.75% 2.40 1.62 48.15%

Description Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var%
Net Sales 231.78 177.75 30.40% 219.16 166.79 31.40% 217.77 171.28 27.14% 211.78 154.51 37.07%
Expenses 174.75 131.22 33.17% 164.24 120.37 36.45% 163.13 125.71 29.77% 158.12 113.09 39.82%
EBITDA 57.03 46.53 22.57% 54.92 46.42 18.31% 54.63 45.57 19.88% 53.66 41.41 29.58%
EBIDTM 24.61% 26.18% 25.06% 27.83% 25.09% 26.61% 25.34% 26.80%
Other Income 5.34 5.66 -5.65% 4.21 5.38 -21.75% 2.97 3.82 -22.25% 3.65 0.76 380.26%
Interest 0.97 0.38 155.26% 2.06 0.17 1,111.76% 1.56 2.94 -46.94% 2.92 5.93 -50.76%
Depreciation 12.87 7.70 67.14% 16.91 7.85 115.41% 15.95 6.88 131.83% 11.44 6.87 66.52%
PBT 48.53 44.11 10.02% 40.16 43.78 -8.27% 40.09 39.57 1.31% 42.96 29.37 46.27%
Tax 9.81 5.76 70.31% 9.66 14.29 -32.40% 9.14 11.97 -23.64% 12.57 10.33 21.68%
PAT 38.72 38.35 0.96% 30.49 29.49 3.39% 30.95 27.60 12.14% 30.38 19.04 59.56%
PATM 16.71% 21.57% 13.91% 17.68% 14.21% 16.12% 14.35% 12.32%
EPS 4.02 4.47 -10.07% 3.16 3.43 -7.87% 3.61 3.22 12.11% 3.54 2.91 21.65%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21
Net Sales 454.23 419.79 371.51 298.59 164.73 Net Sales Growth 8.21% 13.00% 24.42% 81.26% Cost Of Goods Sold 62.94 37.30 28.62 27.85 17.53 Gross Profit 391.29 382.49 342.90 270.74 147.20 GP Margin 86.14% 91.11% 92.30% 90.67% 89.36% Total Expenditure 327.22 300.88 265.18 213.56 122.55 Power & Fuel Cost - 7.74 7.39 8.58 5.75 % Of Sales - 1.84% 1.99% 2.87% 3.49% Employee Cost - 69.00 56.85 57.06 32.07 % Of Sales - 16.44% 15.30% 19.11% 19.47% Manufacturing Exp. - 140.72 115.13 81.45 49.93 % Of Sales - 33.52% 30.99% 27.28% 30.31% General & Admin Exp. - 39.57 55.41 34.08 17.16 % Of Sales - 9.43% 14.91% 11.41% 10.42% Selling & Distn. Exp. - 0.00 0.00 0.00 0.00 % Of Sales - 0% 0% 0% 0% Miscellaneous Exp. - 6.56 1.78 4.55 0.11 % Of Sales - 1.56% 0.48% 1.52% 0.07% EBITDA 127.02 118.91 106.33 85.03 42.18 EBITDA Margin 27.96% 28.33% 28.62% 28.48% 25.61% Other Income 11.69 13.55 1.60 1.27 0.52 Interest 0.62 5.90 9.76 12.81 12.15 Depreciation 18.67 13.45 12.64 13.16 12.52 PBT 119.43 113.11 85.52 60.32 18.03 Tax 31.74 29.12 21.35 18.23 2.52 Tax Rate 26.58% 25.74% 24.96% 30.22% 13.98% PAT 87.69 83.99 64.17 42.09 15.50 PAT before Minority Interest 87.69 83.99 64.17 42.09 15.50 Minority Interest 0.00 0.00 0.00 0.00 0.00 PAT Margin 19.31% 20.01% 17.27% 14.10% 9.41% PAT Growth 4.41% 30.89% 52.46% 171.55% EPS 9.10 8.71 6.66 4.37 1.61

Description TTM Mar 24 Mar 23 Mar 22 Mar 21
Net Sales 880.49 670.55 520.29 400.94 228.67 Net Sales Growth 31.35% 28.88% 29.77% 75.34% Cost Of Goods Sold 131.73 60.69 44.37 50.02 33.45 Gross Profit 748.76 609.86 475.93 350.92 195.23 GP Margin 85.04% 90.95% 91.47% 87.52% 85.38% Total Expenditure 660.24 488.55 385.13 288.96 160.62 Power & Fuel Cost - 14.63 13.71 12.19 9.33 % Of Sales - 2.18% 2.64% 3.04% 4.08% Employee Cost - 111.02 85.93 74.97 43.81 % Of Sales - 16.56% 16.52% 18.70% 19.16% Manufacturing Exp. - 231.38 171.76 102.44 52.76 % Of Sales - 34.51% 33.01% 25.55% 23.07% General & Admin Exp. - 59.51 65.53 43.36 20.06 % Of Sales - 8.87% 12.59% 10.81% 8.77% Selling & Distn. Exp. - 0.00 0.00 0.00 0.00 % Of Sales - 0% 0% 0% 0% Miscellaneous Exp. - 11.31 3.84 5.99 1.22 % Of Sales - 1.69% 0.74% 1.49% 0.53% EBITDA 220.24 182.00 135.16 111.98 68.05 EBITDA Margin 25.01% 27.14% 25.98% 27.93% 29.76% Other Income 16.17 15.61 2.81 1.65 0.52 Interest 7.51 11.48 22.78 22.65 19.89 Depreciation 57.17 29.30 27.51 27.87 20.56 PBT 171.74 156.83 87.68 63.11 28.12 Tax 41.18 42.36 21.91 18.94 8.54 Tax Rate 23.98% 27.01% 24.99% 30.01% 30.37% PAT 130.54 114.47 65.77 44.16 18.16 PAT before Minority Interest 130.53 114.47 65.77 44.16 19.59 Minority Interest -0.01 0.00 0.00 0.00 -1.43 PAT Margin 14.83% 17.07% 12.64% 11.01% 7.94% PAT Growth 14.03% 74.05% 48.94% 143.17% EPS 13.54 11.87 6.82 4.58 1.88

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21
Shareholder's Funds 836.99 176.13 111.71 71.89 Share Capital 85.85 65.52 65.52 16.38 Total Reserves 751.14 110.61 46.19 55.51 Non-Current Liabilities 7.83 82.79 85.08 95.20 Secured Loans 2.03 75.94 70.06 82.65 Unsecured Loans 0.00 0.00 0.00 1.60 Long Term Provisions 1.68 0.96 0.80 0.00 Current Liabilities 33.57 67.31 89.08 40.66 Trade Payables 11.61 10.80 16.09 13.08 Other Current Liabilities 21.91 46.68 51.57 27.58 Short Term Borrowings 0.00 9.78 15.21 0.00 Short Term Provisions 0.05 0.06 6.21 0.00 Total Liabilities 878.39 326.23 285.87 207.75 Net Block 132.52 120.63 122.38 125.68 Gross Block 248.25 222.92 212.03 197.47 Accumulated Depreciation 115.73 102.29 89.64 71.79 Non Current Assets 214.76 168.90 175.02 161.09 Capital Work in Progress 0.00 0.00 0.00 0.78 Non Current Investment 66.99 46.88 46.88 34.30 Long Term Loans & Adv. 10.02 1.32 5.53 0.22 Other Non Current Assets 5.24 0.06 0.23 0.11 Current Assets 663.62 157.34 110.85 46.66 Current Investments 0.00 0.00 0.00 0.00 Inventories 3.93 3.22 2.35 2.74 Sundry Debtors 143.45 85.83 76.33 32.86 Cash & Bank 227.01 12.74 1.83 0.63 Other Current Assets 289.23 8.54 2.14 0.15 Short Term Loans & Adv. 276.19 47.02 28.19 10.28 Net Current Assets 630.06 90.03 21.77 6.00 Total Assets 878.38 326.24 285.87 207.75

Description Mar 24 Mar 23 Mar 22 Mar 21
Shareholder's Funds 874.32 182.96 116.89 72.45 Share Capital 85.85 65.52 65.52 16.38 Total Reserves 788.47 117.45 51.37 56.08 Non-Current Liabilities 67.53 195.21 206.58 173.09 Secured Loans 61.00 200.59 207.38 163.47 Unsecured Loans 14.24 0.00 0.00 0.25 Long Term Provisions 2.54 1.30 0.98 0.04 Current Liabilities 67.22 99.52 97.11 55.00 Trade Payables 29.16 16.88 20.41 16.53 Other Current Liabilities 37.94 66.29 55.27 34.56 Short Term Borrowings 0.07 16.30 15.21 3.90 Short Term Provisions 0.05 0.06 6.21 0.01 Total Liabilities 1,009.07 477.69 420.58 308.77 Net Block 441.88 298.52 303.10 250.81 Gross Block 665.79 471.75 448.83 337.85 Accumulated Depreciation 223.91 173.23 145.73 87.03 Non Current Assets 498.82 301.42 311.17 259.45 Capital Work in Progress 0.00 0.00 0.00 0.00 Non Current Investment 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 33.78 1.79 6.84 7.27 Other Non Current Assets 23.16 1.11 1.23 1.37 Current Assets 510.25 176.27 109.40 49.32 Current Investments 0.00 0.00 0.00 0.00 Inventories 8.13 6.07 5.20 3.39 Sundry Debtors 227.00 107.64 85.54 36.77 Cash & Bank 238.64 38.44 12.08 5.15 Other Current Assets 36.48 12.23 2.14 0.00 Short Term Loans & Adv. 18.62 11.88 4.45 4.01 Net Current Assets 443.03 76.75 12.30 -5.68 Total Assets 1,009.07 477.69 420.57 308.77

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21
Cash From Operating Activity 15.96 25.58 26.80 23.76 PBT 113.11 85.52 60.32 18.03 Adjustment 5.91 21.33 25.08 24.16 Changes in Working Capital -67.26 -49.07 -49.25 -16.86 Cash after chg. in Working capital 51.77 57.78 36.15 25.32 Interest Paid 0.00 0.00 0.00 0.00 Tax Paid -35.80 -32.20 -9.34 -1.56 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 Cash From Investing Activity -167.47 -8.66 -18.47 -5.71 Net Fixed Assets -25.33 -10.89 -13.78 Net Investments -20.11 0.00 -12.58 Others -122.03 2.23 7.89 Cash from Financing Activity 240.58 -6.25 -7.47 -18.71 Net Cash Inflow / Outflow 89.08 10.66 0.86 -0.65 Opening Cash & Equivalents 12.15 1.49 0.63 1.28 Closing Cash & Equivalent 101.23 12.15 1.49 0.63

Description Mar 24 Mar 23 Mar 22 Mar 21
Cash From Operating Activity -3.08 63.78 59.94 43.67 PBT 156.83 87.68 63.11 28.12 Adjustment 26.18 48.75 49.25 39.37 Changes in Working Capital -142.34 -35.25 -39.40 -21.57 Cash after chg. in Working capital 40.67 101.18 72.96 45.92 Interest Paid 0.00 0.00 0.00 0.00 Tax Paid -43.75 -37.40 -13.02 -2.25 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 Cash From Investing Activity -225.87 -20.31 -52.17 -21.24 Net Fixed Assets -25.33 -10.89 -13.78 Net Investments -20.11 0.00 -12.58 Others -180.43 -9.42 -25.81 Cash from Financing Activity 304.21 -17.75 -1.12 -19.05 Net Cash Inflow / Outflow 75.26 25.73 6.64 3.38 Opening Cash & Equivalents 37.43 11.71 5.00 1.61 Closing Cash & Equivalent 112.70 37.43 11.71 5.00

Financial Ratios

Standalone /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21
Book Value (Rs.) 97.49 26.88 17.05 10.97 ROA 13.95% 20.97% 16.92% 7.57% ROE 16.58% 44.59% 46.49% 24.18% ROCE 21.06% 37.32% 37.19% 17.47% Fixed Asset Turnover 1.78 1.71 1.44 0.84 Receivable days 99.68 79.66 66.01 56.70 Inventory Days 3.11 2.74 3.11 5.89 Payable days 109.67 171.47 189.52 252.41 Cash Conversion Cycle -6.88 -89.08 -120.39 -189.82 Total Debt/Equity 0.00 0.65 0.98 1.45 Interest Cover 20.17 9.76 5.71 2.48

Description Mar 24 Mar 23 Mar 22 Mar 21
Book Value (Rs.) 101.84 27.93 17.84 11.06 ROA 15.40% 14.64% 12.11% 6.57% ROE 21.65% 43.87% 46.65% 30.91% ROCE 23.97% 26.88% 27.07% 19.30% Fixed Asset Turnover 1.18 1.13 1.03 0.77 Receivable days 91.08 67.76 55.67 42.83 Inventory Days 3.87 3.95 3.91 4.99 Payable days 138.44 153.39 134.80 165.15 Cash Conversion Cycle -43.49 -81.68 -75.22 -117.33 Total Debt/Equity 0.10 1.44 2.21 2.57 Interest Cover 14.66 4.85 3.79 2.41

Top Investors:

kotak mahindra trustee co ltd a/c kotak multicap fund

bandhan small cap fund

rajasthan global securities private limited

icici prudential pharma healthcare and diaganostics (p.h.d) fund

jupiter india fund

sbi life insurance co. ltd

mukul mahavir agrawal

Annual Reports:

News Update:

Yatharth Hospital inaugurates new super speciality hospital in New Delhi
14th Jul 2025, 16:00 PM

The hospital is also fully equipped to offer emergency and trauma care services, making it a vital addition to Delhi’s healthcare ecosystem
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback